Nomura’s life science investment team, Phase4 Ventures, has been spun out by its management team.
US conglomerate J.M. Huber has agreed to buy the Italian specialty fertilizers producer
Deal is first full exit from specialist healthcare investor's maiden mid-market fund
Buy-and-build specialist looks for portfolio add-ons as it contemplates hitting the road for a new fund in 2023
Three existing partners will lead the California office, which is the GP’s first beyond Europe